Login / Signup

Implementing the Design of Experiments (DoE) Concept into the Development Phase of Orodispersible Minitablets (ODMTs) Containing Melatonin.

Arkadiusz HejdukMichał TeżykEmilia JakubowskaKlaudia KrügerJanina Lulek
Published in: AAPS PharmSciTech (2022)
Development of orodispersible minitablets (ODMTs) requires consideration of aspects related to small dimensions, while ensuring short disintegration time with sufficient mechanical stability. In order to meet these and other critical quality attributes (CQAs), quality by design is encouraged. According to this approach, formulation and compression process factors were systematically studied using design of experiments (Plackett-Burman for screening purposes, full and fractional factorial design for in-depth characterization) to understand their influence on CQAs of orodispersible minitablets containing melatonin. Mathematical models describing the relationships between processing variables and attributes such as resistance to crushing and disintegration time were successfully developed, characterized by high coefficients of determination (R 2 adj = 0.90-0.97) and prediction errors in the range (+2.4 to -10.8%). In conclusion, based on these models, the design space was created for melatonin ODMTs, ensuring the product's quality and process robustness. Moreover, the study demonstrated the suitability of texture analysis as an alternative to compendial measurement methods of resistance to crushing and disintegration time. Graphical abstract.
Keyphrases
  • quality improvement
  • emergency department
  • magnetic resonance imaging
  • computed tomography
  • magnetic resonance
  • contrast enhanced
  • high resolution
  • molecularly imprinted
  • adverse drug